- $404.37m
- $5.07bn
- $965.41m
Claritev Corp expected to post a loss of $3.83 a share - Earnings Preview
US judge rules health insurers, MultiPlan must face price-fixing lawsuits
U.S. RESEARCH ROUNDUP-Claritev, Rocket Pharmaceuticals, Salesforce
Brief: Claritev Appoints Mohamed Ramzy As SVP And General Manager
Brief: Claritev And Burjeel Holdings to expand into Middle East
Claritev Corp reports results for the quarter ended March 31 - Earnings Summary
Brief: Claritev Corporation Reports First Quarter 2025 Results
Brief: Claritev And Lantern Form Strategic Partnership To Enhance Surgical Cost Transparency And Positively Impact Care Quality And Cost Savings
Claritev Corp expected to post a loss of $3.09 a share - Earnings Preview
Claritev Corp reports results for the quarter ended December 31 - Earnings Summary
Claritev Corp expected to post a loss of $9.81 a share - Earnings Preview
Brief: Multiplan Corp Corporate Rebrand To Claritev
Brief: MultiPlan Corp - Dale White Steps Down As Executive Chair Of Board
Brief: MultiPlan Announces Commencement Of Exchange Offers And Consent Solicitations For Outstanding Notes
Brief: Multiplan Announces Comprehensive Refinancing
Multiplan Corp reports results for the quarter ended in September 30 - Earnings Summary
Brief: Multiplan Reports Third Quarter 2024 Results And Updates 2024 Guidance
Multiplan Corp expected to post a loss of $13.70 a share - Earnings Preview
Brief: MultiPlan Corporation’S Reverse Stock Split Becomes Effective